03692 HANSOH PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 10.18X | Oper Margin | 41.5% |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | 35.7% |
| Total Debt/Equity | 0.4% | Return on Equity | 15.2% |
| Price/Book | 6.99X | Return on Assets | 13.8% |
| (HKD 35.900) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 4,649.44 | 3,612.46 | 2,896.90 | 3,318.15 | 3,048.78 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +28.7 | +24.7 | -12.7 | +8.8 | +6.7 |
| Earnings Per Share (HKD) | 0.784 | 0.61 | 0.49 | 0.56 | 0.519 |
| Earnings Per Share Growth (%) | +28.6 | +24.5 | -12.6 | +8.0 | -0.6 |
| Dividend Per Share (HKD) | 0.336 | 0.213 | 0.100 | 0.090 | 0.077 |
| P/E* (X) | 45.79 | 58.88 | 73.31 | 64.06 | 69.20 |
| Yield (%) | 0.94 | 0.59 | 0.28 | 0.25 | 0.21 |
| Dividend Share (%) | 42.90 | 34.92 | 20.42 | 16.06 | 14.86 |
| Book NAV (HKD) | 5.139 | 4.792 | 4.287 | 4.136 | 3.584 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-21 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 12,261 | 10,104 | +21.3 | 9,382 |
| Operating Result | 5,097 | 3,759 | +35.6 | 2,951 |
| Associates | 0 | -2.123 | -100.0 | -13.859 |
| Profit Before Taxation | 5,085 | 3,766 | +35.0 | 2,948 |
| Taxation | 713.357 | 488.652 | +46.0 | 364.681 |
| Profit /( Loss) After Taxation | 4,372 | 3,278 | +33.4 | 2,584 |
| Net Profit | 4,372 | 3,278 | +33.4 | 2,584 |
| Earnings Per Share () | 0.7840 | 0.6097 | +28.6 | 0.4897 |
| Dividend Per Share () | 0.3363 | 0.2129 | +58.0 | 0.1000 |
| Announcement Date | 2025-03-21 | 2024-03-26 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-21 21:40:25
